Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.
2.
3.
6.

Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.

Singh RP, Deep G, Blouin MJ, Pollak MN, Agarwal R.

Carcinogenesis. 2007 Dec;28(12):2567-74. Epub 2007 Oct 4.

PMID:
17916909
7.
8.

Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice.

Raina K, Singh RP, Agarwal R, Agarwal C.

Cancer Res. 2007 Jun 15;67(12):5976-82.

9.

Grape seed extract inhibits in vitro and in vivo growth of human colorectal carcinoma cells.

Kaur M, Singh RP, Gu M, Agarwal R, Agarwal C.

Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6194-202.

11.

Anti-angiogenic efficacy of grape seed extract in endothelial cells.

Agarwal C, Singh RP, Dhanalakshmi S, Agarwal R.

Oncol Rep. 2004 Mar;11(3):681-5.

PMID:
14767522
12.

Up-regulation of insulin-like growth factor binding protein-3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice.

Shukla S, Mishra A, Fu P, MacLennan GT, Resnick MI, Gupta S.

FASEB J. 2005 Dec;19(14):2042-4. Epub 2005 Oct 17.

PMID:
16230333
13.

Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice.

Karashima T, Sweeney P, Slaton JW, Kim SJ, Kedar D, Izawa JI, Fan Z, Pettaway C, Hicklin DJ, Shuin T, Dinney CP.

Clin Cancer Res. 2002 May;8(5):1253-64.

14.

Grape seed extract inhibits angiogenesis via suppression of the vascular endothelial growth factor receptor signaling pathway.

Wen W, Lu J, Zhang K, Chen S.

Cancer Prev Res (Phila). 2008 Dec;1(7):554-61. doi: 10.1158/1940-6207.CAPR-08-0040.

15.
16.
17.
18.

Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenografts.

Williams S, Pettaway C, Song R, Papandreou C, Logothetis C, McConkey DJ.

Mol Cancer Ther. 2003 Sep;2(9):835-43.

19.

The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth.

Ruggeri BA, Robinson C, Angeles T, Wilkinson J 4th, Clapper ML.

Clin Cancer Res. 2002 Jan;8(1):267-74.

20.

A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.

London CA, Sekhon HS, Arora V, Stein DA, Iversen PL, Devi GR.

Cancer Gene Ther. 2003 Nov;10(11):823-32.

PMID:
14605668

Supplemental Content

Support Center